RT @LabSmalley: @weldeiry @Cancer_Cell @BrownUCancer Interesting study. We found something very similar. https://t.co/zzuuoqB9n3

@weldeiry @Cancer_Cell @BrownUCancer Interesting study. We found something very similar. https://t.co/zzuuoqB9n3

@LabSmalley @NatureCancer Thank you so much! We were also intrigued by your very interesting findings when you looked at the TT/IT decision from a different angle 👉https://t.co/IxmpDjJVon

RT @CIR_AACR: Check out here how anti-#PD1 followed by #TargetedTherapy associates with tumor-immune recognition, immunosuppressive signali…

RT @CIR_AACR: Check out here how anti-#PD1 followed by #TargetedTherapy associates with tumor-immune recognition, immunosuppressive signali…

Check out here how anti-#PD1 followed by #TargetedTherapy associates with tumor-immune recognition, immunosuppressive signaling, and prolonged antitumor responses in #melanoma! @labsmalley @KYTsaiLab @ChristinBurd @InnaSmalley @zhihuachen https://t.co/v3ik

RT @CIR_AACR: Check out here how anti-#PD1 followed by #TargetedTherapy associates with tumor-immune recognition, immunosuppressive signali…

RT @CIR_AACR: Check out here how anti-#PD1 followed by #TargetedTherapy associates with tumor-immune recognition, immunosuppressive signali…

RT @CIR_AACR: Check out here how anti-#PD1 followed by #TargetedTherapy associates with tumor-immune recognition, immunosuppressive signali…

RT @CIR_AACR: Check out here how anti-#PD1 followed by #TargetedTherapy associates with tumor-immune recognition, immunosuppressive signali…

RT @CIR_AACR: Check out here how anti-#PD1 followed by #TargetedTherapy associates with tumor-immune recognition, immunosuppressive signali…

RT @CIR_AACR: Check out here how anti-#PD1 followed by #TargetedTherapy associates with tumor-immune recognition, immunosuppressive signali…

Check out here how anti-#PD1 followed by #TargetedTherapy associates with tumor-immune recognition, immunosuppressive signaling, and prolonged antitumor responses in #melanoma! @labsmalley @KYTsaiLab @ChristinBurd @MoffittNews @MDAndersonNews https://t.co/

RT @khoney74: Listening to the #AACR21 panel "New Combinations of Targeted Therapies and Immunotherapies"? Check out this @CIR_AACR paper o…

RT @khoney74: Listening to the #AACR21 panel "New Combinations of Targeted Therapies and Immunotherapies"? Check out this @CIR_AACR paper o…

Listening to the #AACR21 panel "New Combinations of Targeted Therapies and Immunotherapies"? Check out this @CIR_AACR paper on the topic from @LabSmalley https://t.co/P8o8v9w2FY

RT @LabSmalley: Very excited to announce our lab’s first ever immunology paper! Different sequences of immunotherapy and targeted therapy c…

Targeted therapy given after anti-PD-1 leads to prolonged responses in mouse melanoma models through sustained antitumor immunity. https://t.co/n0b7T3KogN https://t.co/MOxT1bFOOW

Targeted therapy given after anti-PD-1 leads to prolonged responses in mouse melanoma models through sustained antitumor immunity https://t.co/j0FyKdageW https://t.co/TRZeuLEXGl

RT @LabSmalley: Very excited to announce our lab’s first ever immunology paper! Different sequences of immunotherapy and targeted therapy c…

Targeted therapy given after anti-PD-1 leads to prolonged responses in mouse melanoma models through sustained antitumor immunity https://t.co/aqMAR9Sm8c https://t.co/TPQEmM40sC

RT @LabSmalley: Very excited to announce our lab’s first ever immunology paper! Different sequences of immunotherapy and targeted therapy c…

New article: Targeted therapy given after anti-PD-1 leads to prolonged responses in mouse melanoma models through sustained antitumor immunity https://t.co/384DKBMWlk #melanoma #oncology https://t.co/FVSBUW7RxZ

Targeted therapy given after anti-PD-1 leads to prolonged responses in mouse melanoma models through sustained antitumor immunity by Manali S Phadke https://t.co/thKP8fxzd4

RT @LabSmalley: Very excited to announce our lab’s first ever immunology paper! Different sequences of immunotherapy and targeted therapy c…

RT @LabSmalley: Very excited to announce our lab’s first ever immunology paper! Different sequences of immunotherapy and targeted therapy c…

Behold the awesome power of mouse models for the pre-clinical testing of drug sequencing. Great work by @LabSmalley and lab.

RT @LabSmalley: Very excited to announce our lab’s first ever immunology paper! Different sequences of immunotherapy and targeted therapy c…

RT @LabSmalley: Very excited to announce our lab’s first ever immunology paper! Different sequences of immunotherapy and targeted therapy c…

Very excited to announce our lab’s first ever immunology paper! Different sequences of immunotherapy and targeted therapy can have very different outcomes! Superb work by Dr. Manali Phadke. #singlecell #immunology #melanoma https://t.co/sieaon2yWw